We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





First Ever COVID-19 Portable Sweat Test Device Delivers Results in 30 Seconds

By LabMedica International staff writers
Posted on 13 Sep 2021
Print article
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
A first-ever COVID-19 portable sweat test device can yield instant results and could support proactive screening in the community.

Researchers at Chulalongkorn University (Bangkok, Thailand) have successfully developed, for the first time, a quick and easy-to-use portable sweat test device for COVID-19 to detect specific scents in sweat caused by bacteria. Sample collection only takes 15 minutes per person, and the results can be obtained in 30 seconds. The sweat test is now being used in community screening. The test is based on the success of the “COVID-19 Sniffer Dogs” project that uses sweat sniffer dogs to detect asymptomatic COVID-19 cases in the community.

People’s sweat may have more than 100 unique scents — be it from the powder, roll-on deodorant, or the bacteria that feed on sweat or skin secretions, then excrete the substances that are mixed with sweat. The portable sweat test device was developed from a commercially available portable chemistry analyzer which is generally used to measure chemicals that are toxic to the environment. To adapt it to detect COVID-19, the researchers installed a specific filter to detect the virus. The advantage of this method is that it can be adapted to detect mutated variants of the virus or other microorganisms. Field tests of the device on 2,000 people alongside the PCR (Polymerase Chain Reaction) testing found the results to be on a par – with 95% sensitivity and 98% specificity.

“For those infected with COVID-19, the bacteria react abnormally to the virus and produce some distinct odors unique to COVID-19 infection,” explained Asst. Prof. Dr. Chadin Kulsing, Department of Chemistry, Faculty of Science, Chulalongkorn University. “The test kit consists of a glass vial and a cotton swab which screeners will receive one each. The screeners would place the cotton swab under the armpit of the person receiving the test and leave it for about 15 minutes. After that, the cotton swab is put in the glass vile, which is then sterilized with UV rays. The technician then draws an appropriate amount of the sample using a suction hose, and pressurizes it into the analyzer to check the results.”

Related Links:
Chulalongkorn University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.